CTKB EPS Estimates
Cytek Biosciences, Inc.
$5.40
+$0.04(+0.84%)
57
Overall
60
Value
58
Tech
55
Quality
Market Cap
$701.26M
Volume
1.07M
52W Range
$3.31 - $6.21
Target Price
$5.56
CTKB EPS estimates: the consensus estimate for Cytek Biosciences, Inc.'s current fiscal year is -$0.30 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CTKB EPS Estimates
- EPS estimate, current quarter
- $-0.05
- EPS estimate, next quarter
- $-0.02
- EPS estimate, current year
- $-0.30
- EPS estimate, next year
- $-0.12
- EPS growth, 3-year
- -100.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.52 |
| 2024 | $-0.05 |
| 2023 | $-0.09 |
| 2022 | $0.02 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTKB | $5.40 | +0.8% | 1.07M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |